REG - PureTech Health PLC - PDMR DEALING - PURCHASE OF SHARES

Puretech HealthAnnouncement

24/09/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250924:nRSX5270Aa&default-theme=true

RNS Number : 5270A  PureTech Health PLC  24 September 2025

PDMR DEALING NOTIFICATION

 1   Details of the person discharging managerial responsibilities/person closely
     associated
 a)  Name                                                         Robert Lyne

                                                                  Sharon Barber-Lui

                                                                  John LaMattina

                                                                  Michele Holcomb
 2   Reason for the notification
 a)  Position/status                                              Robert Lyne - Interim Chief Executive Officer

                                                                  Sharon Barber-Lui - Interim Board Chair; Non-Executive Director

                                                                  John LaMattina - Non-Executive Director

                                                                  Michele Holcomb - Non-Executive Director
 b)  Initial notification/Amendment                               Initial notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         PureTech Health plc
 b)  LEI                                                          213800LVPDNO2Z9T9I39
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Ordinary shares of PureTech Health plc

     Identification code
ISIN GB00BY2Z0H74
 b)  Nature of the transaction                                    Purchase of shares in market
 c)  Price(s) and volume(s)                                       Name               Price(s)            Volume(s)
                                                                  Robert Lyne        GBP 1.23 per share  81,051
                                                                  Sharon Barber-Lui  GBP 1.24 per share  65,250
                                                                  John LaMattina     GBP 1.25 per share  59,100
                                                                  Michele Holcomb    GBP 1.25 per share  29,239
 d)  Aggregated information

- Aggregated volume
Price               Aggregate Volume

                                                            GBP 1.24 per share  234,640

- Price
 e)  Date of the transaction                                      22-23 September 2025
 f)  Place of the transaction                                     London Stock Exchange (XLON)

ISIN GB00BY2Z0H74

b)

Nature of the transaction

Purchase of shares in market

c)

Price(s) and volume(s)

 Name               Price(s)            Volume(s)
 Robert Lyne        GBP 1.23 per share  81,051
 Sharon Barber-Lui  GBP 1.24 per share  65,250
 John LaMattina     GBP 1.25 per share  59,100
 Michele Holcomb    GBP 1.25 per share  29,239

d)

Aggregated information

 -  Aggregated volume

 -  Price

 

 Price               Aggregate Volume
 GBP 1.24 per share  234,640

e)

Date of the transaction

22-23 September 2025

f)

Place of the transaction

London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHPKNBNCBKDACB